Russell Investments Group, Ltd.
Position in KYMR — Kymera Therapeutics, Inc.
CIK 1692234
Seattle, WA
Position in KYMR
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$7,136,256
+$3,070,706 QoQ
Shares Held
62,233
+27.5% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#84
of 273 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. KYMR ranks #46 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in KYMR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,136,256 | 62,233 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $4,065,550 | 48,812 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $3,577,468 | 45,977 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,074,890 | 18,991 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,165,186 | 26,700 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,258,214 | 82,507 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,370,471 | 58,923 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,829,528 | 59,783 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,594,973 | 53,433 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $2,080,630 | 51,757 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $1,250,364 | 49,111 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $432,454 | 31,112 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $417,658 | 18,167 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $827,861 | 27,940 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $721,817 | 28,919 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $500,165 | 22,975 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $400,198 | 20,325 | Shares | Defined | 2022-07-29 | |
| 2021-09-30 | $217,279 | 3,699 | Shares | Sole | 2021-11-08 | |
| 2021-03-31 | $959,219 | 24,684 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $308,698 | 4,979 | Shares | Defined | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||